Cineplex (TSX:CGX) Stock: DEVASTATED by the Pandemic

Cineplex (TSX:CGX) stock got devastated by the COVID-19 pandemic, but vaccine hopes have turned its fortunes around.

| More on:

Cineplex (TSX:CGX) stock has been absolutely devastated by the COVID-19 pandemic. At its lowest point, it was down 87% for the year. As of this writing, it was still down 72%. In recent weeks, Cineplex saw a massive rally that helped pare the losses considerably. However the stock remains a  loser for those who bought at the beginning of the year. In this article, I’ll explore why that is the case and whether the company can recover.

COVID-19 destroyed movie theatres

Movie theatres were among the industries hardest hit by the COVID-19 pandemic. Like airlines and hotels, they saw their revenue tank when lockdowns were implemented. Unlike those industries, however, movie theatres weren’t able to carve out exemptions. For airlines, special categories like “essential travel” helped keep demand afloat at least somewhat. With movie theatres, there were no such exemptions. The result was an unbelievably rapid decline in revenue.

In the second quarter, Cineplex saw a 95% decline in revenue. That’s even worse than what Air Canada experienced. While Air Canada’s 88% revenue decline was bad, CGX at one point was earning no revenue. Early in the lockdowns, it was forced to close all of its theatres. The fact that the company earned any revenue at all in Q2 was merely due to the re-opening that began later in the quarter.

Vaccine uncertainties loom

Of course, all of the issues facing Cineplex today could be resolved overnight by the arrival of a COVID-19 vaccine. If a vaccine is released and quickly given to the majority of the population, then there’ll be no need for further lockdowns. In that scenario, Cineplex would be able to re-open almost all of its theatres overnight. Investors are aware of this, which is probably why CGX rallied more than 100% in the month following Pfizer’s vaccine announcement.

However, it would be a mistake for an investor to bet everything on the arrival of a COVID-19 vaccine. Vaccine deployment still has a number of question marks surrounding it, including:

  • Possible supply chain issues — like those Pfizer recently confessed to.
  • Issues getting the vaccine approved.
  • A new mutation of COVID-19 that the vaccine is not effective against.
  • People refusing to take the vaccine.
  • And many more.

Put simply, there’s no guarantee that a vaccine will magically make COVID-19 go away. If it doesn’t, then lockdowns remain a long-term possibility.

Foolish takeaway

Cineplex stock is down massively this year, but investors who bought in the last month have actually realized a great return. It would be a mistake, though, to take that one-month rally as indicative of future performance. All it would take is a big delay in vaccine deployment to blow CGX’s entire operation. So, the stock remains extremely risky.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Coronavirus

A airplane sits on a runway.
Coronavirus

3 Fresh Stocks I’m Likely Buying in 2025

I am likely buying Air Canada (TSX:AC) stock in 2025.

Read more »

RRSP Canadian Registered Retirement Savings Plan concept
Coronavirus

Canadian RRSP Stocks to Buy Now for Retirement

Alimentation Couche-Tard Inc (TSX:ATD) is a quality retirement stock.

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Coronavirus

Retirees: What Rising Inflation Means for Your CPP Payments

If you aren't getting enough CPP, you can consider investing in stocks and ETFs. Canadian National Railway (TSX:CNR) is one…

Read more »

Coronavirus

Air Canada Stock Is Starting to Get Ridiculously Oversold

Air Canada (TSX:AC) has been beaten down to absurd lows.

Read more »

Coronavirus

Should You Buy Air Canada Stock While it’s Below $18?

Air Canada (TSX:AC) stock is below $18. Should you invest?

Read more »

Illustration of data, cloud computing and microchips
Stocks for Beginners

3 Canadian Stocks That Could Still Double in 2024

These three Canadians stocks have been huge winners already in 2024, but still have room to double again in the…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Can Air Canada Stock Recover in 2024?

Air Canada (TSX:AC) stock remains close to its COVID-19 era lows, even though its business has recovered.

Read more »

A airplane sits on a runway.
Coronavirus

3 Things to Know About Air Canada Stock Before You Buy

Air Canada stock continues to hover below $20 despite the sharp rise in travel demand seen across the industry. What's…

Read more »